Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Sodium benzoate appears ineffective as dementia treatment
Sodium benzoate was ineffective for the treatment of behavioral and psychological symptoms of dementia, according to a 6-week, randomized controlled trial published in Journal of Psychopharmacology.
Alzheimer’s drug may help treat opioid addiction
Galantamine may also someday help treat opioid addiction, according to results published in The American Journal on Addictions.
Log in or Sign up for Free to view tailored content for your specialty!
Circulating cholesterol tied to early-onset Alzheimer’s disease
Study findings indicated that higher levels of cholesterol was associated with early-onset Alzheimer’s disease independently of apolipoprotein E 4 allele, APOE E4.
Cholinesterase inhibitor plus memantine yields neurological benefits for patients with Alzheimer’s
PHILADELPHIA — For patients with Alzheimer’s disease, adding memantine to cholinesterase inhibitor therapy reduced neuropsychiatric symptoms and improved cognition, according to abstracts presented at the American Academy of Neurology Annual Meeting.
Statins may partially abate risk for dementia in concussed patients
Older adults who had a concussion, and also received statins, had a slightly reduced risk for developing dementia later in life, according to findings recently published in JAMA Neurology.
Wellness education, yoga may be effective interventions in patients with mild cognitive impairment
Wellness education appeared to be the most effective intervention for managing patients with mild cognitive impairment, according to findings recently published in JAMA Network Open.
WHO: Exercise, smoking cessation, healthy diet reduce dementia risk
WHO has released its first guidelines on reducing the risk for cognitive decline and dementia for health care providers, governments, policy-makers and other stakeholders, according to a press release.
Attitudes toward physician-assisted deaths vary among those with Alzheimer’s biomarker
The majority of cognitively normal individuals with elevated amyloid-beta, an Alzheimer’s disease biomarker, stated that they neither thought about physician-assisted death for themselves nor would they, recent study data showed
Estrogen therapy may contribute to delaying Alzheimer’s disease
NASHVILLE, Tenn. — Estrogen therapy in women ages 50 to 63 has been shown to affect the metabolic processes associated with later development of Alzheimer’s disease and may offer an opportunity to prevent or delay the disease, according to a presenter at the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting.
Researchers identify dementia that ‘mimics’ Alzheimer’s disease
Researchers have proposed new terminology for a recently recognized late-onset form of dementia that “mimics” Alzheimer’s type dementia, according to a report published in Brain.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read